2007
DOI: 10.1111/j.1468-3083.2007.02413.x
|View full text |Cite
|
Sign up to set email alerts
|

Lichenoid reaction induced by adalimumab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
17
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 3 publications
1
17
0
Order By: Relevance
“…Eleven similar cases have been previously reported in 10 patients, [10][11][12][13][14][15][16][17] including one patient who developed lichenoid reactions to both adalimumab and lenercept. Key features of these 13 eruptions in 12 patients are summarized in Table I.…”
Section: Discussionmentioning
confidence: 62%
See 3 more Smart Citations
“…Eleven similar cases have been previously reported in 10 patients, [10][11][12][13][14][15][16][17] including one patient who developed lichenoid reactions to both adalimumab and lenercept. Key features of these 13 eruptions in 12 patients are summarized in Table I.…”
Section: Discussionmentioning
confidence: 62%
“…In some cases, mucocutaneous lesions were described as having features similar to idiopathic LP, such as violaceous flat-topped polygonal papules, 16 violaceous papular lesions with mild scale, 15 purple-colored erythematosquamous plaques, 12 erythematous polygonal papules, 11 or reticulate white mucosal plaques. 13,14 Other skin lesions were less specific, being described only as an ''erythematous papular rash,'' 10 a ''maculopapular exanthema,'' 17 or white oral plaques. 15 Some features typical of LP were also seen in our two patients.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Targeted therapy with biological agents has also provided new therapeutic options for patients with moderate to severe psoriasis, but paradoxically, there have been reported of new‐onset psoriasis in patients treated with TNF‐α inhibitors, although the exact mechanism remains unclear 2 . Other dermatological side effects have been reported with adalimumab including skin rash, urticaria, eczema, lymphomatoid papulosis, erythema multiforme, lichenoid reactions, vasculitis, rosacea, pityriasis rosea, folliculitis, lupus, herpes zoster, fungal and bacterial infections, actinic keratosis, squamous and basal cell carcinoma 3–7 …”
mentioning
confidence: 99%